Data suggests new Covid 19 strain brings increased risk of reinfection.
Pfizer and BioNTech are among the vaccine manufacturers insisting they'll be able adapt their products if the Omicron variant continues to spread.
Data suggests the new Covid 19 strain - first identified in South Africa - brings an increased risk of reinfection.
The World Health Organistation's calling it a "variant of concern".
But Jonathan Ball - a professor of molecular virology - says we shouldn't get ourselves into a "frenzy".
Controversial Orange Order Parade For Nationalist Road Gets Go-Ahead
Women Aged 50-65 Leaving Workplace Earlier Than Men
Pressure On TikTok To Reveal Viewer Figures Of Harmful Content
Taoiseach Highly Critical Of Israel In UN Address
Gardaí To Begin Pursuit Training In December
Tallaght Hospital's Emergency Department For Children Will Close For Four Days
Poll Reveals Top Priorities For Voters In Upcoming Budget
Man U Legend Cantona Visits Newbridge Silverware
